Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview with Xspray Pharma - Per Andersson, CEO at Xspray Pharma
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Client Success Story: The Childress Family's Financial Journey | The Childress Family, Clients of Goldstone Financial Group
00:10:00
Jeb Bush Discusses Republican Strategy and Economic Growth
00:10:00
Foundations in Wealth Management | Saeed Golkar, Co-Founder & CEO at AKKAR Partners
00:10:00
The opposite of a stuffy BigLaw firm|John B Quinn,Partner,Quinn Emanuel Urquhart & Sullivan LLP
00:10:00
The CEO Outlook highlights that dotdigital Group Plc, a UK-based company, provides software as a service (SaaS) solutions, focusing on omnichannel marketing automation and customer engagement platforms​ |Milan Patel, CEO of Dotdigital
00:00:00
Science Matters with Jeremy Gunawardena / Jeremy Gunawardena Associate Professor of Systems Biology, HMS
00:10:00
Phantom Resources: Advancing High-Potential Gold Discoveries in Nevada with Expert Leadership|Paul Cowley,CEO,Phenom Resources
00:10:00
Tetra Tech CEO Highlights Company’s Consistent Focus on Empowering Innovative Solutions
00:10:00
Inflation Stalemate and Its Impact on Federal Reserve Rate Cuts |Russell Price, Chief Economist , Ameriprise Financial Inc.
00:10:00
committed and has built a community of over 5,000 incredible, driven, ambitious builders|Matthew Colford,Investment Partner,Human Capital
00:10:00
Blue Owl Capital's Role in Stable Investment Solutions | Marc Lipschultz, Co-president , Blue Owl Capital.
00:10:00
Emmerson PLC's Hayden Locke Highlights Development and Funding Progress for World-Class Khemisset Potash Project at Cape Town Mining Conference